Researchers at the University of Pittsburgh are pioneering a new approach to blood pressure monitoring—using the devices we carry with us every day. Ramakrishna Mukkamala, professor of bioengineering ...
Measuring blood pressure (BP) at home rather than in the clinic is more reliable and better at predicting risk for heart attack or stroke. However, in a brief report published in JAMA Cardiology, ...
South Korean company Sky Labs is pushing cuffless, ring-type blood pressure monitoring into hospital wards, working to automate routine vital sign checks. Recently, it launched the CART ON system, ...
A large Scottish study suggests that those with hypertension who regularly monitor their readings at home and share the ...
BD (Becton, Dickinson and Company) has launched a new medical device designed to give clinicians continuous, noninvasive visibility into patients’ blood pressure. Dubbed the HemoSphere Stream Module, ...
Missing blood pressure (BP) records within 2 years prior to diagnosis were associated with substantially higher risks for major adverse cardiovascular events (MACEs) and all-cause mortality in older ...
A team of researchers at the University of California San Diego has developed a new and improved wearable ultrasound patch for continuous and noninvasive blood pressure monitoring. Their work marks a ...
Researchers validated a novel wearable ultrasound blood pressure (BP) sensor, confirming its accuracy and safety across diverse clinical settings. This non-invasive sensor offers continuous, reliable ...
Becton, Dickinson and Company BDX, popularly known as BD, recently announced the launch of its HemoSphere Stream Module, a new solution that enables continuous, noninvasive blood pressure monitoring ...
Vanessa is a lead writer at CNET, reviewing and writing about the latest smartwatches and fitness trackers. She joined the brand first as an on-camera reporter for CNET's Spanish-language site, then ...
This study aimed to investigate the characteristics of out-of-office blood pressure (BP) measurements in patients with apparent treatment-resistant hypertension (aRH) enrolled from 15 tertiary care ...